USD 6.42
(-10.71%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 14.62 Million USD | -26.65% |
2022 | 19.93 Million USD | 449.6% |
2021 | 3.62 Million USD | -31.78% |
2020 | 5.31 Million USD | 1.86% |
2019 | 5.22 Million USD | -98.34% |
2018 | 313.78 Million USD | 12.31% |
2017 | 279.38 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | -100.0% |
2014 | 1.93 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 14.68 Million USD | 0.42% |
2024 Q2 | 19.74 Million USD | 34.49% |
2023 Q1 | 10.01 Million USD | -49.77% |
2023 Q2 | 59 Thousand USD | -99.41% |
2023 FY | 14.62 Million USD | -26.65% |
2023 Q4 | 14.62 Million USD | 42905.88% |
2023 Q3 | 34 Thousand USD | -42.37% |
2022 Q2 | 14.79 Million USD | 0.11% |
2022 Q1 | 14.77 Million USD | 232.89% |
2022 Q4 | 19.93 Million USD | 0.63% |
2022 Q3 | 19.81 Million USD | 33.91% |
2022 FY | 19.93 Million USD | 449.6% |
2021 Q1 | - USD | -100.0% |
2021 Q2 | 5.29 Million USD | 0.0% |
2021 Q3 | 14.99 Million USD | 183.26% |
2021 Q4 | 4.43 Million USD | -70.4% |
2021 FY | 3.62 Million USD | -31.78% |
2020 Q4 | 5.31 Million USD | 0.0% |
2020 FY | 5.31 Million USD | 1.86% |
2020 Q1 | - USD | 0.0% |
2019 Q2 | 314.87 Million USD | 0.16% |
2019 FY | 5.22 Million USD | -98.34% |
2019 Q3 | 354.41 Million USD | 12.56% |
2019 Q1 | 314.37 Million USD | 0.19% |
2018 Q2 | 280.3 Million USD | 0.16% |
2018 Q3 | 280.76 Million USD | 0.16% |
2018 Q4 | 313.78 Million USD | 11.76% |
2018 FY | 313.78 Million USD | 12.31% |
2018 Q1 | 279.84 Million USD | 0.16% |
2017 Q3 | 278.93 Million USD | 0.17% |
2017 Q2 | 278.46 Million USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | 279.38 Million USD | 0.0% |
2017 Q4 | 279.38 Million USD | 0.16% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q3 | 1.74 Million USD | -10.08% |
2015 Q2 | 1.94 Million USD | 0.21% |
2015 Q4 | - USD | -100.0% |
2015 FY | - USD | -100.0% |
2015 Q1 | 1.94 Million USD | 0.21% |
2014 Q4 | 1.93 Million USD | 0.0% |
2014 FY | 1.93 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Cosmos Health Inc. | 3.03 Million USD | -381.725% |
Safety Shot Inc | 304.9 Thousand USD | -4695.561% |
Bright Green Corporation | 201.78 Thousand USD | -7146.398% |
Embecta Corp. | 1.62 Billion USD | 99.1% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 95.278% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 83.945% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 97.016% |
Dynavax Technologies Corporation | 252.41 Million USD | 94.207% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 97.085% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | -9.725% |
Pacira BioSciences, Inc. | 513.79 Million USD | 97.154% |
PainReform Ltd. | 30 Thousand USD | -48640.0% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -2612.625% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -2612.625% |
SCYNEXIS, Inc. | 12.15 Million USD | -20.257% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -12383.672% |
Alpha Teknova, Inc. | 13.25 Million USD | -10.346% |
Procaps Group, S.A. | 28.41 Million USD | 48.532% |
Theratechnologies Inc. | 51.26 Million USD | 71.475% |
Harrow Health, Inc. | 183.17 Million USD | 92.017% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -16706.897% |
Biofrontera Inc. | 804 Thousand USD | -1718.657% |
DURECT Corporation | 2.7 Million USD | -441.155% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 55.953% |
Cronos Group Inc. | 1.55 Million USD | -837.909% |
OptiNose, Inc. | 611 Thousand USD | -2293.126% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 97.066% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | 57.233% |
RedHill Biopharma Ltd. | 455 Thousand USD | -3113.626% |
Organogenesis Holdings Inc. | 60.74 Million USD | 75.929% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -14.376% |
Radius Health, Inc. | 339.66 Million USD | 95.695% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | -42.542% |
Phibro Animal Health Corporation | 458.28 Million USD | 96.809% |
Procaps Group S.A. | 28.41 Million USD | 48.532% |
Alvotech | 1.02 Billion USD | 98.577% |
TherapeuticsMD, Inc. | 6.53 Million USD | -123.852% |
Viatris Inc. | 16.18 Billion USD | 99.91% |
Rockwell Medical, Inc. | 8.29 Million USD | -76.317% |
Aytu BioPharma, Inc. | 10.87 Million USD | -34.43% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -4251.902% |
Tilray Brands, Inc. | 287.93 Million USD | 94.922% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 87.867% |
Shineco, Inc. | 10.01 Million USD | -45.967% |
PetIQ, Inc. | 437.82 Million USD | 96.66% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Incannex Healthcare Limited | 210 Thousand USD | -6862.857% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 94.339% |
Alimera Sciences, Inc. | 64.48 Million USD | 77.326% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 38.51 Million USD | 62.035% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -10723.975% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | -113.231% |
Clever Leaves Holdings Inc. | 720 Thousand USD | -1930.833% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -64932.912% |
Avadel Pharmaceuticals plc | 32.75 Million USD | 55.366% |
Hempacco Co., Inc. | 5.93 Million USD | -146.535% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 1.02 Billion USD | 98.577% |
Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 73.99% |
Lantheus Holdings, Inc. | 616.12 Million USD | 97.627% |
Currenc Group, Inc. | 2.5 Million USD | -483.253% |
Kamada Ltd. | 7.43 Million USD | -96.585% |
Indivior PLC | 235.66 Million USD | 93.795% |
Evoke Pharma, Inc. | 5 Million USD | -192.44% |
Flora Growth Corp. | 942 Thousand USD | -1452.229% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -64932.912% |
Evolus, Inc. | 120.35 Million USD | 87.851% |
HUTCHMED (China) Limited | 48.18 Million USD | 69.657% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 97.518% |
Akanda Corp. | 2.49 Million USD | -485.546% |